Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC

NCT01769066 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

117

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Sequential Gefitinib With Pemetrexed/Platinum
DRUG: Pemetrexed/Platinum

Sponsor

Fudan University